http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2471520-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_159ee470c35e07b00ba42fa69479627e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_314ceac477d91a62d862e66a925502ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_54ac25d0c50f692f2ccee2f291b474d8
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-734
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-711
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
filingDate 2011-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2013-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1467465deb184a95d5d3e2646026af18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7cd9650ff48da36cb0af94b53c4da5d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47e4be9b937f66282fa1d07f973762ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1dacb045732d2dc7ce5e15cc90cae36f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65a04a73a6d45a61c7d24e5aae8e1bbc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7763b0f3ee5e53c028fc1fc5207f246a
publicationDate 2013-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2471520-C1
titleOfInvention Method of treating breast cancer
abstract FIELD: medicine. n SUBSTANCE: invention refers to medicine, particularly to oncology, and may be applied in treating breast cancer. Breast is resected. Coletex-Mex textile tissue is applied for 4-7 days in 7-10 postoperative days on the postoperative scar and remained breast tissues, and changed 2 times a day. For the following 4-7 days, Coletex-D hydrogel tissue is applied and coated with Coletex-SMT textile tissue in the same regiment. The applications for 8-10 hours a day are combined with radiation teletherapy to SRD 20 Gy - 25 Gy. The radiation teletherapy is combined with the applications of Coletex gel DNA hydrogel coated with Coletex-Mex textile tissues from above changed twice a day. The radiation teletherapy is followed by the application of Coletex-SMT tissue and Coletex-Mex tissues changed every 12 hours to complete rehabilitation. n EFFECT: method provides fast healing of the postoperative wound, reduced length of the beginning of radiation and chemotherapy, minimal rate of complications and side reactions thereby improving patient's quality of life. n 1 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2626914-C1
priorityDate 2011-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2176922-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2234961-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2349264-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419497675
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID114681

Total number of triples: 32.